Guangdong South China Pharmaceutical Group

Guangdong South China Pharmaceutical Group is a prominent pharmaceutical enterprise headquartered in Dongguan, China, with a history dating back to its origins as a state-owned factory under the Ministry of Railways. The company specializes in the research, development, and large-scale production of both Traditional Chinese Medicine (TCM) and chemical pharmaceuticals. Its extensive product portfolio is particularly recognized for cardiovascular treatments, including its flagship Compound Danshen Tablets and Apocynum Venetum (Luo Bu Ma) preparations. Operating multiple GMP-certified production lines, the group maintains a significant presence in the Chinese domestic market through a robust distribution network. The company continues to focus on the modernization of TCM and the production of high-quality generic chemical drugs to address chronic and acute health conditions.